Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana (NYSE: HUM) and partners announced the return of the National Mall of Pickleball for its third year, scheduled for September 19-21, 2025 in Washington, D.C. The event is relocating to a more central location at 12th Street NW with an expanded footprint featuring 11 temporary pickleball courts.
This free, three-day event themed "Moves That Serve" will offer activities including pickleball lessons, clinics with pros, and walk-on play opportunities. The Trust for the National Mall is also hosting a contest for "America's Ultimate Pickleball Duos" until August 15, 2025, where eight winning pairs will receive an all-expense-paid trip to compete in the Ultimate Duo Tournament.
Humana (NYSE: HUM) has expanded its science-based targets with a new SBTi-validated financial institution target. The company commits to having 67.3% of its listed equity and corporate bond portfolio set SBTi-validated targets by 2029 from a 2022 base year.
This new target complements Humana's existing commitments, including a 30% reduction in Scope 3 emissions from purchased goods, services, and upstream transportation by 2032. The company has revised its investment policy to incorporate SBTi-aligned climate commitments, demonstrating leadership in climate action within the healthcare and insurance sectors.
The Humana Foundation, the philanthropic arm of Humana (NYSE: HUM), has announced a $50,000 donation to support recovery efforts in Kentucky communities affected by recent severe storms and tornadoes. The donation will be directed to the Foundation for Appalachian Kentucky to address urgent needs in the aftermath of devastating storms that hit Laurel and Pulaski Counties on May 16, 2025, claiming at least 19 lives.
Additionally, Humana employees are participating in a dedicated giving campaign, with the Humana Foundation matching all donations. The funds will be distributed among various nonprofit organizations including the Team Kentucky Storm Relief Fund, United Way of Laurel County, Samaritan's Purse, and American Red Cross.
Humana Foundation CEO Tiffany Benjamin has been named to the inaugural TIME100 Philanthropy list, recognizing influential figures in philanthropy. Benjamin, who has led the foundation since 2022, is acknowledged for her work in advancing health equity and establishing innovative community health initiatives. Notable achievements include co-founding Face the Fight, a veteran suicide prevention initiative now supported by over 200 organizations. Benjamin also serves as Board Chair of the Center for Disaster Philanthropy and was previously recognized with the Outstanding Corporate Philanthropy Leadership Award and named among the 100 Most Influential Black Americans.
CenterWell Specialty Pharmacy, part of Humana (NYSE: HUM), has won the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the seventh time in eight years. The award recognizes customer satisfaction and patient care excellence based on the highest average net promoter scores from Zitter Insights surveys throughout 2024.
The pharmacy manages therapies for chronic and complex illnesses, offering clinical and educational services through its Centers of Excellence program. The program provides specialized treatment guidance for conditions including cancer, autoimmune disorders, neuromuscular disorders, pulmonary conditions, and rare diseases. Additionally, CenterWell assists patients in accessing financial assistance programs for specialty drugs.